Waters Corporation WAT
470.90 USD 0.00 (+0.00%)
At closeNov 12, 2026, 9:15 AM EST
468.01 -2.89 -0.61%
Pre-market · Nov 12, 9:15 AM ET
Day range unavailable
282.77 52-week range 483.33
- YTD
- +23.98%
- 1 year
- +21.56%
News
zacks.com Waters Gains FDA Clearance for Flow Cytometry Tests for Blood Cancers WAT gains FDA clearance for two blood cancer diagnostic tests, advancing standardized testing and expanding its clinical diagnostics portfolio.
benzinga.com Waters Says BD OneFlow LST Test And BD OneFlow B-CLPD T1 Test Receives FDA 510(k) Clearance For Identifying B-Cell Non-Hodgkin Lymphoma BD OneFlow™ LST and BD OneFlow™ B-CLPD T1 Tests now FDA 510(k)-cleared in U.S. for identifying B-cell non-Hodgkin lymphoma (NHL)Delivers 96.3% sensitivity and 98.2% specificity1 in identifying…
prnewswire.com Waters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and Lymphoma BD OneFlow™ LST and BD OneFlow™ B-CLPD T1 Tests now FDA 510(k)-cleared in U.S. for identifying B-cell non-Hodgkin lymphoma (NHL) Delivers 96.3% sensitivity and 98.2% specificity1 in identifying…
zacks.com Waters Expands Proteomics Reach With MOBILion Systems Acquisition WAT expands its proteomics footprint with the MOBILion acquisition, boosting mass spectrometry capabilities, AI-driven research and clinical testing prospects.
seekingalpha.com Madison Mid Cap Fund Q3 2026 Portfolio Activity The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace…
benzinga.com Citigroup Maintains Buy on Waters, Raises Price Target to $536 Citigroup analyst Joanne Wuensch maintains Waters (NYSE:WAT) with a Buy and raises the price target from $470 to $536.
benzinga.com JP Morgan Maintains Neutral on Waters, Raises Price Target to $470 JP Morgan analyst Casey Woodring maintains Waters (NYSE:WAT) with a Neutral and raises the price target from $435 to $470.
benzinga.com TD Cowen Maintains Buy on Waters, Raises Price Target to $530 TD Cowen analyst Dan Brennan maintains Waters (NYSE:WAT) with a Buy and raises the price target from $515 to $530.- benzinga.com Barclays Maintains Overweight on Waters, Raises Price Target to $530 Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $500 to $530.
benzinga.com RBC Capital Maintains Outperform on Waters, Raises Price Target to $525 RBC Capital analyst Dan Leonard maintains Waters (NYSE:WAT) with a Outperform and raises the price target from $475 to $525.
benzinga.com Keybanc Maintains Overweight on Waters, Raises Price Target to $500 Keybanc analyst Paul Knight maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $460 to $500.
benzinga.com Waters CEO Says AI Is Already Fueling Lab Demand As Drugmakers Race to Accelerate Discovery Waters Corporation (WAT) shares jump on strong Q3 earnings beat, raised 2026 outlook, and the strategic acquisition of MOBILion Systems.
benzinga.com Waters Q3 2026 Earnings Call Transcript Waters (NYSE:WAT) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Waters Sees Q4 Adj EPS $4.58-$4.68 vs $4.67 Est; Sees Sales $1.801B-$1.819B vs $1.789B Est Waters (NYSE:WAT) is looking for Q4 Adj EPS of $4.58-$4.68 vs $4.67 analyst estimate. sees sales of $1.801 billion-$1.819 billion vs $1.789 billion analyst estimate.- benzinga.com Waters Q3 Adj. EPS $4.10 Beats $4.00 Estimate, Sales $1.767B Beat $1.754B Estimate Waters (NYSE:WAT) reported quarterly earnings of $4.10 per share which beat the analyst consensus estimate of $4.00 by 2.5 percent. This is a 20.59 percent increase over earnings of $3.40 per share…
benzinga.com Waters Raises FY2026 Adj EPS Guidance from $14.45-$14.65 to $14.60-$14.70 vs $14.58 Est; Raises FY2026 Sales Guidance from $6.415B-$6.476B to $6.479B-$6.497B vs $6.456B Est Waters (NYSE:WAT) raises FY2026 Adj EPS guidance from $14.45-$14.65 to $14.60-$14.70 vs $14.58 analyst estimate. Raises FY2026 sales outlook from $6.415 billion-$6.476 billion to $6.479…- benzinga.com Waters Corporation Acquires Ion Mobility Separation Technology Maker MOBILion Systems; Financial Terms Not Disclosed Waters Corporation (NYSE:WAT), a global life sciences and diagnostics leader, today announced that it has acquired MOBILion Systems, Inc., the pioneer of SLIM high-resolution ion mobility separation…
benzinga.com AMD, Shopify On Deck Tuesday As AI Spending, Merchant Growth Face Test Advanced Micro Devices headlines Tuesday’s reports, with investors looking for evidence that AI demand can withstand a sharp pullback in the stock. Shopify, Pfizer, Eaton, Marathon Petroleum and…
benzinga.com Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.93% on an annualized basis producing an average annual return of 11.87%. Currently, Waters has a market capitalization of…- benzinga.com Waters And Labcorp To Expand Access To BD Onclarity HPV Assay Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic,…
benzinga.com Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.71% on an annualized basis producing an average annual return of 11.7%. Currently, Waters has a market capitalization of…
benzinga.com TD Cowen Maintains Buy on Waters, Raises Price Target to $515 TD Cowen analyst Dan Brennan maintains Waters (NYSE:WAT) with a Buy and raises the price target from $475 to $515.- benzinga.com Barclays Maintains Overweight on Waters, Raises Price Target to $500 Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $460 to $500.
benzinga.com Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth Micron, Sandisk and Nvidia lead seven S&P 500 stocks that more than doubled quarterly revenue. Six sell AI hardware.
benzinga.com The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited The S&P 500 hit a record high Tuesday, but only 15 of its 504 stocks did too. The median member trades 25% below its own peak.- benzinga.com Guggenheim Maintains Buy on Waters, Raises Price Target to $490 Guggenheim analyst Subbu Nambi maintains Waters (NYSE:WAT) with a Buy and raises the price target from $440 to $490.
- benzinga.com If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.95% on an annualized basis producing an average annual return of 11.99%. Currently, Waters has a market capitalization of…
benzinga.com Microsoft To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Monday Analysts raised targets for INSP, SECZ, CLF and WAT, while cutting targets for CRDO, CL and TTMI; ratings remained unchanged.- benzinga.com Goldman Sachs Maintains Buy on Waters, Raises Price Target to $515 Goldman Sachs analyst Evie Koslosky maintains Waters (NYSE:WAT) with a Buy and raises the price target from $465 to $515.
benzinga.com $1000 Invested In Waters 20 Years Ago Would Be Worth This Much Today Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.59% on an annualized basis producing an average annual return of 11.74%. Currently, Waters has a market capitalization of…
benzinga.com This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.
benzinga.com This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday Analysts upgraded SFNC, OBIO, and more.
benzinga.com This Illumina Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Analysts upgraded Sagimet, Figure, Illumina, Martin Marietta and Waters, raising price targets and improving ratings.- benzinga.com UBS Upgrades Waters to Buy, Raises Price Target to $490 UBS analyst Doug Schenkel upgrades Waters (NYSE:WAT) from Neutral to Buy and raises the price target from $375 to $490.
benzinga.com If You Invested $1000 In Waters Stock 20 Years Ago, You Would Have This Much Today Waters (NYSE:WAT) has outperformed the market over the past 20 years by 2.82% on an annualized basis producing an average annual return of 12.05%. Currently, Waters has a market capitalization of…
benzinga.com This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday Top Wall Street analysts upgraded BWX Technologies, The Macerich Company, and Waters Corporation. Check out analyst ratings and price targets.- benzinga.com Piper Sandler Upgrades Waters to Overweight, Raises Price Target to $480 Piper Sandler analyst David Westenberg upgrades Waters (NYSE:WAT) from Neutral to Overweight and raises the price target from $400 to $480.
- benzinga.com Citigroup Maintains Buy on Waters, Raises Price Target to $470 Citigroup analyst Joanne Wuensch maintains Waters (NYSE:WAT) with a Buy and raises the price target from $425 to $470.
- benzinga.com TD Cowen Upgrades Waters to Buy, Raises Price Target to $475 TD Cowen analyst Dan Brennan upgrades Waters (NYSE:WAT) from Hold to Buy and raises the price target from $408 to $475.
- benzinga.com RBC Capital Maintains Outperform on Waters, Raises Price Target to $475 RBC Capital analyst Dan Leonard maintains Waters (NYSE:WAT) with a Outperform and raises the price target from $435 to $475.
- benzinga.com Evercore ISI Group Maintains Outperform on Waters, Raises Price Target to $420 Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a Outperform and raises the price target from $410 to $420.
- benzinga.com Wells Fargo Maintains Equal-Weight on Waters, Raises Price Target to $400 Wells Fargo analyst Evan Stampler maintains Waters (NYSE:WAT) with a Equal-Weight and raises the price target from $370 to $400.
- benzinga.com Barclays Maintains Overweight on Waters, Raises Price Target to $460 Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $425 to $460.
- benzinga.com Waters Sees Q3 Adj EPS $3.95-$4.05 vs $3.99 Est; Sees Sales $1.745B-$1.762B vs $1.753B Est Waters (NYSE:WAT) is looking for Q3 Adj EPS of $3.95-$4.05 vs $3.99 analyst estimate. sees sales of $1.745 billion-$1.762 billion vs $1.753 billion analyst estimate.
- benzinga.com Waters Raises FY2026 Adj EPS Guidance from $14.40-$14.60 to $14.45-$14.65 vs $14.51 Est; Raises FY2026 Sales Guidance from $6.405B-$6.455B to $6.415B-$6.476B vs $6.436B Est Waters (NYSE:WAT) raises FY2026 Adj EPS guidance from $14.40-$14.60 to $14.45-$14.65 vs $14.51 analyst estimate. Raises FY2026 sales outlook from $6.405 billion-$6.455 billion to $6.415…
benzinga.com Waters Q2 Adj. EPS $3.05 Beats $3.01 Estimate, Sales $1.645B Beat $1.623B Estimate Waters (NYSE:WAT) reported quarterly earnings of $3.05 per share which beat the analyst consensus estimate of $3.01 by 1.33 percent. This is a 3.39 percent increase over earnings of $2.95 per share…- benzinga.com Goldman Sachs Maintains Buy on Waters, Raises Price Target to $425 Goldman Sachs analyst Patrick Donnelly maintains Waters (NYSE:WAT) with a Buy and raises the price target from $380 to $425.
- benzinga.com Morgan Stanley Maintains Equal-Weight on Waters, Raises Price Target to $390 Morgan Stanley analyst Kallum Titchmarsh maintains Waters (NYSE:WAT) with a Equal-Weight and raises the price target from $350 to $390.
- benzinga.com RBC Capital Initiates Coverage On Waters with Outperform Rating, Announces Price Target of $435 RBC Capital analyst Dan Leonard initiates coverage on Waters (NYSE:WAT) with a Outperform rating and announces Price Target of $435.
- benzinga.com Evercore ISI Group Maintains Outperform on Waters, Raises Price Target to $410 Evercore ISI Group analyst Vijay Kumar maintains Waters (NYSE:WAT) with a Outperform and raises the price target from $380 to $410.